Source Natural Foods and Herbal Supplements Limited
BSE: SOURCENTRL
Prev Close
137.55
Open Price
151
Volume
259
Today Low / High
137.7 / 151
52 WK Low / High
118.95 / 216
Range
131 - 145
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 137.8, reflecting a change of 0.25 (0.18175%). The expected target range on the BSE is 131 - 145. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Source Natural Foods and Herbal Supplements Limited Graph
Source Natural Foods and Herbal Supplements Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Source Natural Foods and Herbal Supplements Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 137.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 137.80 | 139.18 | 125.26 - 153.10 |
| 140.56 | 112.44 - 168.67 | ||
| 141.93 | 99.35 - 184.51 | ||
| Bearish Scenario | 137.80 | 136.42 | 122.78 - 150.06 |
| 135.04 | 108.04 - 162.05 | ||
| 133.67 | 93.57 - 173.77 |
Overview of Source Natural Foods and Herbal Supplements Limited
ISIN
INE679C01027
Industry
Medical - Pharmaceuticals
Vol.Avg
1,810
Market Cap
887,008,954
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
18.58
DCF
119
Financial Ratios Every Investor Needs
Stock Dividend of SOURCENTRL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2019-09-12 | September 12, 19 | 1 | 1 | 2019-09-13 | 2019-09-22 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 44.92 Cr | 37.76 Cr | 7.17 Cr | 0.1596 | 0.00 Cr | 0.00 Cr | 4.13 Cr | 2.90 Cr | 4.51 | 5.22 Cr | 0.0646 |
| 2024-03-31 | 27.30 Cr | 16.78 Cr | 10.52 Cr | 0.3855 | 0.00 Cr | 0.59 Cr | 3.43 Cr | 1.74 Cr | 2.70 | 4.42 Cr | 0.0636 |
| 2023-03-31 | 19.77 Cr | 9.85 Cr | 9.92 Cr | 0.5017 | 0.00 Cr | 0.70 Cr | 2.99 Cr | 2.12 Cr | 3.30 | 3.59 Cr | 0.1073 |
| 2022-03-31 | 21.52 Cr | 9.43 Cr | 12.09 Cr | 0.5618 | 0.00 Cr | 0.61 Cr | 3.43 Cr | 2.43 Cr | 3.78 | 4.25 Cr | 0.1130 |
| 2021-03-31 | 24.88 Cr | 9.91 Cr | 14.97 Cr | 0.6016 | 0.00 Cr | 0.52 Cr | 4.45 Cr | 3.37 Cr | 5.24 | 4.56 Cr | 0.1356 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 7.23 Cr | 37.33 Cr | 14.98 Cr | 22.3573 Cr | 7.41 Cr | 0.18 Cr | 6.07 Cr | 3.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 14.4070 Cr |
| 2024-03-31 | 5.86 Cr | 23.65 Cr | 4.20 Cr | 19.4533 Cr | 0.00 Cr | -5.86 Cr | 4.30 Cr | 4.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 3.6262 Cr |
| 2023-03-31 | 2.91 Cr | 21.69 Cr | 3.97 Cr | 17.7168 Cr | 0.02 Cr | -2.89 Cr | 3.82 Cr | 4.58 Cr | 0.00 Cr | 0.45 Cr | -1.98 Cr | 3.4234 Cr |
| 2022-03-31 | 0.87 Cr | 19.32 Cr | 3.73 Cr | 15.5957 Cr | 0.04 Cr | -0.83 Cr | 2.76 Cr | 5.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 3.2110 Cr |
| 2021-03-31 | 2.71 Cr | 17.22 Cr | 4.06 Cr | 13.1632 Cr | 0.93 Cr | -1.77 Cr | 1.74 Cr | 4.21 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 3.6835 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.5582 Cr | -5.3315 Cr | 6.0208 Cr | -0.6477 Cr | 0.0000 Cr | 7.2260 Cr | -0.0895 Cr | 2.9040 Cr | 0.0000 Cr | 0.0000 Cr | -1.7734 Cr |
| 2024-03-31 | 2.5012 Cr | 0.2935 Cr | 0.1534 Cr | 2.6948 Cr | 2.9481 Cr | 5.8621 Cr | 0.0000 Cr | 1.7365 Cr | -0.0200 Cr | 0.0000 Cr | -0.4843 Cr |
| 2023-03-31 | 2.5125 Cr | 0.0557 Cr | -0.5271 Cr | 2.5125 Cr | 2.0411 Cr | 2.9140 Cr | 0.0000 Cr | 2.7358 Cr | -0.0181 Cr | 0.0000 Cr | -1.0532 Cr |
| 2022-03-31 | -0.7032 Cr | 0.0677 Cr | -1.1976 Cr | -2.2457 Cr | -1.8331 Cr | 0.8729 Cr | -1.5425 Cr | 3.6815 Cr | -0.8917 Cr | 0.0000 Cr | -1.0270 Cr |
| 2021-03-31 | 4.4631 Cr | -2.0482 Cr | 0.3197 Cr | 3.2085 Cr | 2.6927 Cr | 2.7060 Cr | -1.2546 Cr | 4.0463 Cr | -0.1844 Cr | 0.0000 Cr | -0.5081 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 16.07 Cr | 14.32 Cr | 1.74 Cr | 0.1086 | 0.98 Cr | 0.63 Cr | 0.97 | 1.28 Cr | 0.0390 |
| 2024-12-31 | 10.45 Cr | 7.08 Cr | 3.37 Cr | 0.3224 | 1.40 Cr | 1.02 Cr | 1.58 | 1.67 Cr | 0.0975 |
| 2024-09-30 | 10.26 Cr | 7.34 Cr | 2.91 Cr | 0.2839 | 1.12 Cr | 0.84 Cr | 1.30 | 1.37 Cr | 0.0819 |
| 2024-06-30 | 8.16 Cr | 6.83 Cr | 1.33 Cr | 0.1626 | 0.63 Cr | 0.42 Cr | 0.65 | 0.90 Cr | 0.0515 |
| 2024-03-31 | 6.83 Cr | 4.93 Cr | 1.90 Cr | 0.2778 | 1.22 Cr | 0.32 Cr | 0.50 | 1.43 Cr | 0.0472 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 7.23 Cr | 0.00 Cr | 7.23 Cr | 13.74 Cr | 6.07 Cr | 27.67 Cr | 3.93 Cr | 37.33 Cr | 14.98 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 7.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -20.71 Cr |
| 2024-09-30 | 7.52 Cr | 0.00 Cr | 7.52 Cr | 1.63 Cr | 5.16 Cr | 26.21 Cr | 4.03 Cr | 31.29 Cr | 10.58 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 5.86 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -19.45 Cr |
| 2024-03-31 | 5.86 Cr | 0.07 Cr | 5.86 Cr | 7.51 Cr | 4.30 Cr | 18.07 Cr | 4.20 Cr | 23.65 Cr | 4.20 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.96 Cr | 0.52 Cr | 0.00 Cr | 0.00 Cr | 0.52 Cr | 3.48 Cr | 2.96 Cr | 0.00 Cr | 0.52 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1982
Gender: male
Year Born: 1981
FAQs about Source Natural Foods and Herbal Supplements Limited
The CEO is Arvind Varchaswi Narasimhan.
The current price is ₹137.80.
The range is ₹118.95-216.
The market capitalization is ₹88.70 crores.
The P/E ratio is 30.58.
The company operates in the Healthcare sector.
Overview of Source Natural Foods and Herbal Supplements Limited (ISIN: INE679C01027) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹88.70 crores and an average daily volume of 1,810 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.